亚太区股市早段全面偏软 惟台股逆市屡创纪录高
美股昨晚个别发展,达拉斯联储4月制造业指数逼近三年高远胜预期,但美国3月耐用品及核心耐用订单初值弹幅远低预期,加上本周是美企季绩高峰期及联储局今明两天议息,市场观望气氛浓厚,近三分二蓝筹受压,尤其是联合健康、家得宝、3M、Honeywell、Travelers、沃尔玛、可口可乐和宝洁跌1%-2%,但获大摩升价的运通升4.2%,Nike、高盛及波音也升逾1%,支持道指仅反覆逆吐不足0.2%;季绩胜预期的升降机制造商奥的斯股价急涨7%,亚马逊及绩前Tesla升逾2%及1%,其他大型科网股也普遍有小量升幅,费城半导体指数更续升1.7%,支持纳指及标普续升近0.9%及0.2%齐创收市纪录高。此外,欧盟拟推疫苗护照,容许已接种疫苗的旅客可於夏季到欧洲旅游,航空邮轮股受捧,矿业及银行股也造好,带动欧洲主要股市全面回升,尤其是西班牙弹近1%,富时涨近0.4%四连涨。
美股期货全面窄幅靠稳。不过,亚太区股市早段普遍受压。美元兑日圆於亚洲续微弹0.1%至108.18,日经继昨晚反覆回升0.4%後,今早反覆回软,高低见29,187/29,066,现造29,087,微吐0.1%。
南韩首季季调後实际GDP初值季增再度扩至1.6%胜预期,但韩股继昨天续升1%,今早反覆微吐,高低见3,223/3,205,现造3,215,微吐2点。澳洲200反覆(曾高见7,053)续吐近0.5%报7,013。新西兰长周末假後复市扭两连弹,报12,613,回吐0.3%。
港股继昨天反覆回吐0.5%结束两连弹後,今早在再遭主要股东折让近7%配股抽水的药明生物(02269.HK)低开5.1%、因垄断案遭当局立案调查的美团(03690.HK)低开1.6%及申洲(02313.HK)低开1.3%拖累,恒指低开57点或0.2%报28,895。
沪指及深成继昨天受制3,500及14,500,在白酒、钢铁及券商板块主导倒跌近1%後,今早低开1点及0.1%,分别报3,440及14,211。
新加坡扭三连升,报3,202,微吐0.1%。马来西亚昨天高收续升0.9%後,今早也扭三连升,报1,622,微吐1点。
不过,台湾加权指数继昨天续升1.6%高收再创破顶後,今早高见17,630,现造17,594,续升0.1%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.